{
  "pmcid": "12499376",
  "sha256": "8f811dc3629da2b09ddb8d856e4523361b375a7c6da18bb4f99a1a4ffc700d62",
  "timestamp_utc": "2025-11-09T22:30:29.258642+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.841877572016465,
    "reading_ease": 35.365532407407414,
    "word_count": 243
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Long-term Outcomes of Invasive vs. Noninvasive Treatments for Intermittent Claudication: A Systematic Review and Meta-Analysis of Randomised Controlled Trials"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 1,
        "evidence": "Participants were adults with IC."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Interventions included invasive treatments (angioplasty, revascularization) and noninvasive treatments (supervised exercise therapy, best medical therapy)."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study compares the long-term outcomes of invasive and noninvasive treatments for IC."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcomes were quality of life (QoL), ankle-brachial pressure index (ABPI), and maximum walking distance (MWD) over 2 to 7 years."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Randomisation and allocation concealment methods were not specified."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding details were not provided."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 1379 patients from 11 RCTs were included."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Invasive treatments significantly improved MWD (pooled MD = 64.94, 95% CI [10.77, 115.12], p = .02) and ABPI (pooled MD = 0.15, 95% CI [0.04, 0.26], p = .006)."
      },
      "Harms": {
        "score": 1,
        "evidence": "However, they were associated with a higher rate of complications, including increased amputation risk (pooled OR = 2.46, 95% CI [0.44, 13.94], p = .31)."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: PROSPERO CRD42023494962."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 13,
    "max_score": 25
  }
}